neurology

News in brief: Lymphopenia concern with MS therapies; Neuroscience unit wins reprieve; Gene replacement therapy effective in SMA

Lymphopenia concern with MS therapies Cladribine has shown good efficacy and safety in real world treatment of relapsing multiple sclerosis but lymphopenia and herpes virus infections appear more common than seen in clinical trials, according to German researchers. In a study involving 270 patients treated with cladribine, they observed a profound reduction of both relapses ...

Already a member?

Login to keep reading.


OR
© 2021 the limbic